Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial

Deonna M. Ackermann, Amelia K. Smit, Monika Janda, Cathelijne H. van Kemenade, Mbathio Dieng, Rachael L. Morton, Robin M. Turner, Anne E. Cust, Les Irwig, Jolyn K. Hersch, Pascale Guitera, H. Peter Soyer, Victoria Mar, Robyn P.M. Saw, Donald Low, Cynthia Low, Dorothy Drabarek, David Espinoza, Jon Emery, Peter MurchieJohn F. Thompson, Richard A. Scolyer, Anthony Azzi, Alister Lilleyman, Katy J.L. Bell*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)
11 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences